174 related articles for article (PubMed ID: 3037955)
1. Leukotrienes and the pulmonary microcirculation.
Garcia JG; Noonan TC; Jubiz W; Malik AB
Am Rev Respir Dis; 1987 Jul; 136(1):161-9. PubMed ID: 3037955
[No Abstract] [Full Text] [Related]
2. [Regulation of pulmonary vessels].
Voelkel NF
Prax Klin Pneumol; 1984 Jan; 38(1):1-7. PubMed ID: 6324159
[No Abstract] [Full Text] [Related]
3. The evolution and future horizons of research on the metabolism of arachidonic acid by 5-lipoxygenase.
Piper PJ
J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):441-4. PubMed ID: 6088618
[TBL] [Abstract][Full Text] [Related]
4. Leukotrienes, allergy and inflammation.
Nijkamp FP; Sitsen JM
Pharm Weekbl Sci; 1982 Dec; 4(6):165-71. PubMed ID: 6296757
[TBL] [Abstract][Full Text] [Related]
5. Leukotrienes.
Hammarström S
Annu Rev Biochem; 1983; 52():355-77. PubMed ID: 6311078
[TBL] [Abstract][Full Text] [Related]
6. Immunopathogenetic roles of leukotrienes in human diseases.
Goetzl EJ; Payan DG; Goldman DW
J Clin Immunol; 1984 Mar; 4(2):79-84. PubMed ID: 6327762
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandins, thromboxanes, and leukotrienes: formation and biological roles.
Samuelsson B
Harvey Lect; 1979-1980; 75():1-40. PubMed ID: 233643
[No Abstract] [Full Text] [Related]
8. Differences in the formation and metabolism of leukotrienes B4 and C4 in the human lung.
Kumlin M; Dahlén SE; Granström E
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1018-22. PubMed ID: 2823552
[No Abstract] [Full Text] [Related]
9. The leukotrienes in allergy and inflammation.
Marx JL
Science; 1982 Mar; 215(4538):1380-3. PubMed ID: 6278589
[No Abstract] [Full Text] [Related]
10. [Pharmacology of the leukotrienes].
Sirois P; Borgeat P
J Pharmacol; 1984; 15 Suppl 1():53-68. PubMed ID: 6328128
[TBL] [Abstract][Full Text] [Related]
11. Leukotrienes and their possible significance for the pathogenesis of asthma.
Verhagen J; Bruynzeel PL
Allergol Immunopathol (Madr); 1985; 13(6):531-7. PubMed ID: 3008545
[TBL] [Abstract][Full Text] [Related]
12. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.
Samuelsson B
Science; 1983 May; 220(4597):568-75. PubMed ID: 6301011
[TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid and leukotrienes in clinical dermatology.
Kragballe K; Voorhees JJ
Curr Probl Dermatol; 1985; 13():1-10. PubMed ID: 2982547
[No Abstract] [Full Text] [Related]
14. [Leukotrienes and the cardiovascular system].
Sagach VF
Patol Fiziol Eksp Ter; 1986; (1):84-9. PubMed ID: 3010220
[No Abstract] [Full Text] [Related]
15. Prospects for the inhibition of leukotriene synthesis.
Bach MK
Biochem Pharmacol; 1984 Feb; 33(4):515-21. PubMed ID: 6322805
[No Abstract] [Full Text] [Related]
16. Interactions between leukotrienes and other eicosanoids.
Sirois P; Borgeat P; Rola-Pleszczynski M; Gagnon L; Hébert RL; Plante GE
Prog Clin Biol Res; 1985; 199():75-84. PubMed ID: 2999826
[No Abstract] [Full Text] [Related]
17. The role of leukotrienes in human pathophysiology.
Raible DG; Lichtenstein LM
Ann N Y Acad Sci; 1988; 524():334-44. PubMed ID: 2837967
[No Abstract] [Full Text] [Related]
18. Leukotrienes: a new class of mediators of immediate hypersensitivity reactions and inflammation.
Samuelsson B
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():1-13. PubMed ID: 6303067
[No Abstract] [Full Text] [Related]
19. [Leukotrienes and other lipoxygenase derivatives: a group of pharmacologically very active lipid mediators].
Maclouf J; Mencia-Huerta JM
Pathol Biol (Paris); 1985 Jan; 33(1):5-8. PubMed ID: 2983287
[No Abstract] [Full Text] [Related]
20. [Prostanoids (prostaglandins, thromboxanes, prostacyclin) and leukotrienes].
Kecskeméti V
Orv Hetil; 1983 Dec; 124(49):2967-74. PubMed ID: 6318174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
